BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ

Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30

$3.51−0.08 (-2.23%)

Close on Nov 12, 2026Market cap $30.65MP/E –Yield –

BriaCell Therapeutics statistics

57 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jul 31, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $30.65M; $280.48M
Enterprise Value: $9.27M; $148.62M

Share statisticsIndustry

Shares Outstanding: 9M; 58M
Shares Change (QoQ): 20.1%; 0.48%
Float: 5M; 49M
Shares Held by Insiders: 46.3%; 12.1%
Shares Held by Institutions: 46.7%; 56.4%

Short sellingIndustry

Short Interest: 807,641; –
Short Interest Change: 2.30%; -0.76%
Days to Cover: 12.47; 5.13

Stock price statisticsIndustry

52-Week High: $13.09; –
52-Week Low: $2.60; –
20-Day Moving Average: $3.43; –
50-Day Moving Average: $3.72; –
200-Day Moving Average: $3.77; –
Average True Range (14): $0.28; –
Price Change (1 Week): 7.34%; 1.51%
Price Change (1 Month): -4.88%; -2.37%
Price Change (3 Months): 2.03%; -21.1%
Price Change (6 Months): -13.3%; -22.8%
Price Change (YTD): -50.6%; -22.6%
Price Change (1 Year): -66.7%; -21.0%
Price Change (3 Years): -99.4%; -24.8%
Price Change (5 Years): -99.8%; -76.9%
Average Volume (10 Days): 77,436; –
Average Volume (20 Days): 68,226; –
Average Volume (90 Days): 217,651; –
Relative Volume: 0.20; 0.80
Relative Strength Index (14): 48.8; 44.7
Volatility (1 Year): 113.6%; 80.2%
Beta (5 Years): 0.89; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -154.3%; -40.7%
Return on Capital Employed (ROCE): -231.1%; -38.1%

Financial positionIndustry

Current Ratio: 2.76; 3.31
Quick Ratio: 2.57; 2.41
Interest Coverage: -1216.77; -6.35

EfficiencyIndustry

Profits Per Employee: -$1.13M; -$683.67K
Employee Count: 31; 75
WACC: 9.33%; 10.0%

Income statement (TTM)Industry

Operating Income: -$36.05M; -$20.99M
Net Income: -$34.90M; -$21.61M
EBITDA: -$36.05M; -$16.85M

Balance sheetIndustry

Cash & Short-Term Investments: $20.54M; $67.18M
Net Cash (Debt): $20.54M; $16.98M
Net Cash Per Share: $2.35; $0.72
Working Capital: $14.06M; $78.52M

Cash flow (TTM)Industry

Operating Cash Flow: -$28.65M; -$12.27M
Capital Expenditures: -$127.05K; -$944.00K
Free Cash Flow: -$28.78M; -$18.20M
FCF Per Share: -$3.30; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -113.9%; -21.0%
FCF Yield: -93.9%; -9.44%
Buyback Yield: -103.8%; -0.73%
Shareholder Yield: -103.8%; 0.00%

Taxes and interestIndustry

Interest Expense: $29.63K; $2.97M

Scores and fair valueIndustry

Altman Z-Score: -10.74; 0.26
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	BCTX	S&P 500	Difference	BCTX per year	S&P 500 per year
1 month	-9.3%	-2.7%	−6.6 pts
3 months	+2.9%	-1.7%	+4.7 pts
Year to date	-50.6%	+11.9%	−62.5 pts
1 year	-65.3%	+12.0%	−77.3 pts
3 years	-99.4%	+78.2%	−177.6 pts	-81.9%	+21.2%
5 years	-99.8%	+73.2%	−173.0 pts	-70.3%	+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M BCTX shares were sold short on Oct 30, 2026, up 2.3% from the previous report. At recent volumes it would take 12.5 days to buy them back. Over the last 20 sessions, 58.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	807,641	+2.3%	64,791	12.5
Oct 15, 2026	789,493	+1.3%	55,447	14.2
Sep 30, 2026	779,096	-1.7%	200,420	3.9
Sep 15, 2026	792,224	+9.4%	92,530	8.6
Aug 31, 2026	723,836	+81.5%	967,776	1.0
Aug 14, 2026	398,913	-2.3%	119,474	3.3
Jul 31, 2026	408,294	-8.9%	68,628	6.0
Jul 15, 2026	448,078	+17.9%	241,432	1.9
Jun 30, 2026	380,150	+0.8%	96,201	4.0
Jun 15, 2026	377,009	-56.6%	250,931	1.5
May 29, 2026	867,761	+84.6%	269,245	3.2
May 15, 2026	470,162	-0.5%	256,138	1.8

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?